Paradoxical Effects of Erucic Acid-A Fatty Acid With Two-Faced Implications.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search or meta-analytic methodology (Oxford CEBM Level 5).
PubMed 40202517 · doi:10.1093/nutrit/nuaf032
What was done
This paper reviewed the published literature on the health implications of erucic acid, a monounsaturated fatty acid found in rapeseed and mustard oils. The authors examined evidence regarding reported toxicities (such as myocardial lipidosis and hepatic steatosis) that prompted regulatory restrictions in several Western nations, alongside limited human studies evaluating mustard oil consumption in Asian populations.
What was found
The abstract reports no numerical effect sizes or quantitative results. It notes that erucic acid is linked to adverse outcomes like myocardial lipidosis and hepatic steatosis, which led to dietary intake limits in the United States, European countries, New Zealand, and Australia. In contrast, limited human studies reported that erucic-acid-rich mustard oil (30%-50%) was associated with protective roles in acute myocardial infarction, ischemic heart disease, and neurologic disorders.
Why it matters
This review highlights the discrepancy between regulatory toxicity thresholds based on historical data and observational reports of cardiovascular benefits from high-erucic-acid mustard oil. Understanding these dual effects helps contextualize international regulatory limits and dietary recommendations.
Limits
The abstract outlines a narrative review rather than a systematic review or meta-analysis. No sample sizes, quantitative estimates, confidence intervals, or specific human study designs are provided in the abstract, and the underlying evidence base for human benefit remains limited.
Cited by
- supports Erucic acid has been associated with cardiac toxicities in animal studies.